OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Variation in responses to incretin therapy: Modifiable and non-modifiable factors
Gregory O. Austin, Alejandra Tomás
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 6
Gregory O. Austin, Alejandra Tomás
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 6
Showing 6 citing articles:
Non-canonical G protein signaling
Bernd Nürnberg, Sandra Beer‐Hammer, Ellen Reisinger, et al.
Pharmacology & Therapeutics (2024) Vol. 255, pp. 108589-108589
Open Access | Times Cited: 7
Bernd Nürnberg, Sandra Beer‐Hammer, Ellen Reisinger, et al.
Pharmacology & Therapeutics (2024) Vol. 255, pp. 108589-108589
Open Access | Times Cited: 7
GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?
Abdelilah Arredouani
Pharmacology & Therapeutics (2025), pp. 108824-108824
Closed Access
Abdelilah Arredouani
Pharmacology & Therapeutics (2025), pp. 108824-108824
Closed Access
Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults
Marco Infante, F Silvestri, Nathalia Padilla, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1303-1303
Open Access
Marco Infante, F Silvestri, Nathalia Padilla, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1303-1303
Open Access
Tirzepatide 10 and 15 mg versus semaglutide 2.4 mg in people with obesity or overweight with type 2 diabetes: An indirect treatment comparison
Emily R. Hankosky, Xuanyao He, Raleigh Malik, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Emily R. Hankosky, Xuanyao He, Raleigh Malik, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
A novel free fatty acid receptor agonist improving metabolic health in Drosophila models
Kashi Brunetti, Elisabetta Catalani, Simona Del Quondam, et al.
Pharmacological Research (2025), pp. 107769-107769
Open Access
Kashi Brunetti, Elisabetta Catalani, Simona Del Quondam, et al.
Pharmacological Research (2025), pp. 107769-107769
Open Access
Reduced Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Therapy in People With Type 1 Diabetes and Genetic Forms of Obesity
Matthew P. Klein, Halis Kaan Aktürk, Janet K. Snell‐Bergeon, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 2
Matthew P. Klein, Halis Kaan Aktürk, Janet K. Snell‐Bergeon, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 2
In vivofunctional profiling and structural characterisation of the humanGlp1rA316T variant
Liliane El Eid, Kieran Deane-Alder, Roxana-Maria Rujan, et al.
(2024)
Closed Access
Liliane El Eid, Kieran Deane-Alder, Roxana-Maria Rujan, et al.
(2024)
Closed Access
Incretin-Related Drugs and Nutrition
Ayumi Arai, Shunsuke Kobayashi, Fumitaka Okajima
Nippon Eiyo Shokuryo Gakkaishi (2024) Vol. 77, Iss. 5, pp. 333-338
Open Access
Ayumi Arai, Shunsuke Kobayashi, Fumitaka Okajima
Nippon Eiyo Shokuryo Gakkaishi (2024) Vol. 77, Iss. 5, pp. 333-338
Open Access
